JonathanIsaacMacyMD

Clinical Trials

• A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Start of enrollment: 2012 Apr 01

  Completed

• Cornea Donor Study Start of enrollment: 2000 Jan 10

  Completed

  Not Applicable

• Travoprost 3-Month Safety and Efficacy Study Start of enrollment: 2011 Nov 01

  Completed

  Phase 3

• Zylet vs TobraDex in Blepharokeratoconjunctivitis Start of enrollment: 2007 Jan 01

  Completed

  Phase 4

• A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients Start of enrollment: 1997 Aug 01

  Completed

  Phase 3

• Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness Start of enrollment: 2018 Sep 01

  Unknown status

  Not Applicable

• An Open Label Comparing the Short Term Efficacy of Lacrisert Start of enrollment: 2016 Nov 01

  Unknown status

  Phase 4

• Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Start of enrollment: 2014 Sep 01

  Completed

  Phase 3

• Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma Start of enrollment: 2015 Sep 01

  Completed

  Phase 3

• Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% Start of enrollment: 2011 Feb 01

  Completed

  Phase 3

• Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis Start of enrollment: 2012 May 01

  Completed

  Phase 2

• Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis Start of enrollment: 2013 Feb 01

  Terminated

  Phase 3

• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Start of enrollment: 2014 Jun 01

  Completed

  Phase 2

• Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion Start of enrollment: 2017 Jul 31

  Completed

  Phase 3

• Join now to see all